仁和药业: insider trades · France · AMF SZSE:000650 FR FR · AMF Mcap 7.9Bn€
Discover the full management transaction log of 仁和药业, a publicly traded company based in France. Shares are listed on FR FR, under the authority of AMF. Market capitalisation: €7.9bn. The latest transaction was filed on 1 November 2023 — Purchase. Among the most active insiders: 杨潇. Every trade is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 3.54 Bn€
Gross profit 1.31 Bn€ 37% margin
Net income 393.2 M€ 11.1% margin
Balance sheet & cash
Market cap 7.91 Bn€
Total debt 2.2 M€
Free Cash Flow 776.7 M€
Last declaration on 1 November 2023
Declarations 9 total
Executives ● Purchase7 SZSE
560,000 shares
SZSE:173000007057391260 · 1 Nov 2023
Ideal exit: 28 Jul 2024 (T+270) Executives ● Purchase10 SZSE
1,300,000 shares
SZSE:173000007054267330 · 31 Oct 2023
Ideal exit: 27 Jul 2024 (T+270) Executives ● Purchase10 SZSE
4,427,500 shares
SZSE:173000007051128960 · 30 Oct 2023
Ideal exit: 26 Jul 2024 (T+270) Executives ● Purchase14 SZSE
3,146,900 shares
SZSE:173000006991606460 · 28 Sept 2023
Ideal exit: 24 Jun 2024 (T+270) Executives ● Purchase14 SZSE
660,000 shares
SZSE:173000006953737440 · 20 Sept 2023
Ideal exit: 16 Jun 2024 (T+270) Executives ● Purchase14 SZSE
940,000 shares
SZSE:173000006909179360 · 7 Sept 2023
Ideal exit: 3 Jun 2024 (T+270) Executives ● Purchase14 SZSE
460,000 shares
SZSE:173000006903481820 · 5 Sept 2023
Ideal exit: 1 Jun 2024 (T+270) Executives ● Purchase7 SZSE
1,253,100 shares
SZSE:173000006862917340 · 28 Aug 2023
Ideal exit: 24 May 2024 (T+270) Executives ● Purchase7 SZSE
1,020,200 shares
SZSE:173000006854778340 · 25 Aug 2023
Ideal exit: 21 May 2024 (T+270)
